Ankündigung • Jun 09
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.425251 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 106,312,738
Price\Range: AUD 0.004
Discount Per Security: AUD 0.00024
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Board Change • May 20
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Jan 13
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 240,000,000
Price\Range: AUD 0.005
Discount Per Security: AUD 0.0003
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Ankündigung • Oct 20
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 366,666,667
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00018
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Ankündigung • Sep 24
AdAlta Limited, Annual General Meeting, Nov 19, 2025 AdAlta Limited, Annual General Meeting, Nov 19, 2025. Location: piper alderman, level 23, 459 collins street, melbourne vic 3000, and, Australia New Risk • Aug 28
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Negative equity (-AU$598k). Shareholders have been substantially diluted in the past year (94% increase in shares outstanding). Revenue is less than US$1m (AU$696k revenue, or US$454k). Market cap is less than US$10m (AU$4.62m market cap, or US$3.01m). Board Change • Aug 18
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Michelle Burke was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Jun 30
Adalta Limited Announces Resignation of Iain Ross as Non-Executive Director, Effective Date Is June 30, 2025 AdAlta Limited announced that non-executive director, Iain Ross, has tendered his resignation effective from 30 June 2025 due to the potential for conflicts of interest to emerge between AdAlta and another company he serves. Ankündigung • May 01
AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million. AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.286446 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 317,148,667
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00003
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 100,000,000
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00018
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 11,666,667
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00003
Transaction Features: Rights Offering Board Change • Dec 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Iain Ross was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Oct 23
AdAlta Limited Appoints Kevin Lynch as Consultant Chief Medical Officer of AdCella AdAlta Limited announced a significant addition to its AdCella leadership team. Kevin Lynch MB BS has been appointed as Consultant Chief Medical Officer. In this role he will help support the selection of in-licensed cellular immunotherapies and the design and execution of Phase I clinical trials by AdCella. Consultant CMO-AdCella, Kevin Lynch MB BS, based in Australia with leading industry and China haematology/oncology experience. Dr. Lynch has taken on the role of Consultant CMO-AdCella, as this AdAlta subsidiary continues to execute its East to West cellular immunotherapy strategy. Dr. Lynch is a highly experienced industry physician. His 30 years' experience span all stages of clinical development, regulatory and reimbursement approvals and post-registration medical activities. He has contributed to multiple transformational therapies in haematology/oncology at both early- to late-stage therapies, including imatinib, nilotinib, lenalidomide and pomalidomide. He has led high level regulatory interactions in Australia (including for cell therapies), China, South Korea, Singapore, Europe, and other markets. Importantly, he has also provided senior input into multiple interactions with the US Food & Drug Administration (FDA). Dr. Lynch is Co-Founder of PopulusBio srl. His previous leadership roles include CMO at Antengene and senior medical and clinical roles at Celgene and Novartis. Ankündigung • Oct 18
AdAlta Limited, Annual General Meeting, Nov 20, 2024 AdAlta Limited, Annual General Meeting, Nov 20, 2024. Location: at piper alderman, level 23, 459 collins stree, melbourne, 3000, Australia New Risk • Jun 05
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Market cap is less than US$100m (AU$16.1m market cap, or US$10.7m). New Risk • Feb 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Market cap is less than US$10m (AU$9.99m market cap, or US$6.54m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Ankündigung • Dec 20
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 1.66 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 60,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 23,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing Ankündigung • Dec 19
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 0.46 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 23,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing New Risk • Nov 15
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$8.41m market cap, or US$5.49m). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Ankündigung • Nov 03
AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million. AdAlta Limited has filed a Follow-on Equity Offering in the amount of AUD 1.23 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 61,500,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0
Transaction Features: Subsequent Direct Listing Ankündigung • Sep 22
AdAlta Limited, Annual General Meeting, Nov 22, 2023 AdAlta Limited, Annual General Meeting, Nov 22, 2023, at 11:01 AUS Eastern Standard Time. Location: Piper Alderman, Level 23, 459 Collins Street Melbourne Victoria Australia Agenda: To provide business update to Shareholders. New Risk • Aug 26
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.1m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 0.5% per year over the past 5 years. Market cap is less than US$10m (AU$10.2m market cap, or US$6.51m). Minor Risks Shareholders have been diluted in the past year (41% increase in shares outstanding). Revenue is less than US$5m (AU$3.5m revenue, or US$2.3m). Ankündigung • Jul 13
AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million. AdAlta Limited has completed a Follow-on Equity Offering in the amount of AUD 3.153759 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 51,303,619
Price\Range: AUD 0.025
Discount Per Security: AUD 0.0015
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 74,846,752
Price\Range: AUD 0.025
Discount Per Security: AUD 0.0015
Security Features: Attached Options
Transaction Features: Rights Offering Board Change • Mar 09
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 03
First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022) First half 2023 results: AU$0.009 loss per share (improved from AU$0.015 loss in 1H 2022). Revenue: AU$1.11m (up 53% from 1H 2022). Net loss: AU$2.82m (loss narrowed 23% from 1H 2022). Board Change • Feb 21
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 10
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Nov 17
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Oct 05
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 30
Full year 2022 earnings released: AU$0.022 loss per share (vs AU$0.024 loss in FY 2021) Full year 2022 results: AU$0.022 loss per share. Revenue: AU$2.76m (down 31% from FY 2021). Net loss: AU$6.06m (loss widened 7.7% from FY 2021). Board Change • Aug 17
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 28
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Bob Peach was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 29
Full year 2021 earnings released: AU$0.024 loss per share (vs AU$0.037 loss in FY 2020) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: AU$3.99m (up 4.2% from FY 2020). Net loss: AU$5.63m (loss narrowed 6.3% from FY 2020). Reported Earnings • Mar 03
First half 2021 earnings released: AU$0.021 loss per share (vs AU$0.037 loss in 1H 2020) The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: AU$806.5k (up 100% from 1H 2020). Net loss: AU$4.51m (loss narrowed 25% from 1H 2020). 
